eHealth Devices

Global eHealth Devices Market to Reach US$29.5 Billion by 2030

The global market for eHealth Devices estimated at US$19.1 Billion in the year 2024, is expected to reach US$29.5 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Blood Pressure Meters, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$11.7 Billion by the end of the analysis period. Growth in the Fever Meters segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.2 Billion While China is Forecast to Grow at 12.1% CAGR

The eHealth Devices market in the U.S. is estimated at US$5.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global eHealth Devices Market – Key Trends & Drivers Summarized

Why Are eHealth Devices Revolutionizing the Delivery of Modern Healthcare?

eHealth devices are redefining the way healthcare is delivered, monitored, and managed across the globe, merging digital innovation with medical precision to enable real-time, personalized, and remote care. These devices—ranging from wearable fitness trackers and smartwatches to remote patient monitors, connected glucometers, smart inhalers, and ECG patches—are part of a growing digital health ecosystem that empowers individuals to manage their health outside traditional clinical settings. The increasing emphasis on preventive care, aging populations, and the rise in chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders are accelerating the global demand for these devices. Unlike traditional diagnostics, eHealth devices offer continuous, non-invasive health data monitoring, transforming episodic care into proactive and predictive healthcare.

Healthcare providers, insurers, and patients are all embracing the shift toward connected health management. In hospitals and clinics, eHealth devices are being used for real-time tracking of vital signs, enabling timely intervention and reducing emergency visits. At the consumer level, rising health consciousness and smartphone penetration are making digital health solutions more accessible and user-friendly. The COVID-19 pandemic further fueled this trend, highlighting the importance of remote monitoring, virtual consultations, and contactless diagnostics. Governments and private players are investing heavily in digital health infrastructure, regulatory frameworks, and public health apps, supporting a broader digital transformation. As the boundaries between clinical care, home-based care, and fitness technology blur, eHealth devices are emerging as essential tools in modern healthcare delivery systems.

How Are Lifestyle Trends and Chronic Disease Burden Powering Market Demand for eHealth Devices?

The rising prevalence of lifestyle-related disorders and chronic illnesses is a major catalyst for the adoption of eHealth devices. Diabetes, hypertension, obesity, and cardiovascular diseases continue to place immense strain on healthcare systems worldwide. eHealth devices provide a non-invasive, efficient means of managing these conditions by allowing real-time monitoring and early detection of symptoms. For instance, continuous glucose monitors (CGMs), digital blood pressure monitors, and portable ECG devices enable patients to track their vitals daily and share data instantly with healthcare professionals. This self-monitoring not only empowers patients but also improves clinical outcomes by enabling physicians to make informed, data-backed decisions.

Concurrently, the wellness industry is embracing eHealth technology, with wearables that monitor activity levels, sleep patterns, stress indicators, and calorie burn gaining widespread popularity. Younger consumers are increasingly interested in biohacking and quantified self-movements, while older adults are adopting eHealth devices for fall detection, medication reminders, and remote health monitoring. The aging global population, particularly in countries like Japan, Germany, and Italy, is boosting demand for devices that support independent living and chronic disease management. The integration of eHealth devices with smartphones, cloud platforms, and AI-based analytics is creating personalized and predictive health dashboards that cater to diverse needs. These shifts in consumer behavior and medical necessity are turning eHealth devices into essential everyday tools, bridging gaps between clinical visits and daily health management.

Who Are the Key Innovators and Industry Players Driving the eHealth Devices Boom?

The eHealth devices market is being propelled by a mix of tech giants, medtech companies, health startups, and pharmaceutical firms, all working to redefine the continuum of care. Leading players such as Apple, Fitbit (now part of Google), Withings, Medtronic, Abbott, Philips, and Omron are continuously innovating to expand the capabilities and accuracy of wearable and connected health devices. Startups are also playing a vital role, introducing niche products focused on women’s health, remote diagnostics, fertility tracking, mental wellness, and AI-powered symptom analysis. These players are leveraging machine learning algorithms, biosensors, and cloud computing to create scalable, intelligent health platforms that work in real time.

Partnerships between hardware manufacturers, software developers, insurers, and healthcare providers are becoming increasingly common. Hospitals are integrating eHealth device data into their electronic health records (EHRs), enabling a more holistic view of patient health. Meanwhile, insurers are offering premium discounts and wellness incentives to policyholders who use approved health monitoring devices. Regulatory agencies such as the FDA and EMA are expanding frameworks to support digital therapeutics and connected diagnostics, legitimizing eHealth devices as recognized components of treatment protocols. In emerging markets, governments are launching eHealth programs that include mobile health kits, telehealth integration, and wearable distribution to underserved areas. This multi-stakeholder collaboration, backed by rising investment and technological advancement, is transforming eHealth devices from wellness accessories into core components of global healthcare ecosystems.

What’s Driving the Accelerated Growth in the Global eHealth Devices Market?

The growth in the eHealth devices market is driven by several key factors rooted in technological innovation, end-use demand shifts, and evolving healthcare delivery models. On the technology side, advancements in wearable biosensors, Bluetooth-enabled diagnostics, data encryption, and miniaturization have significantly improved the accuracy, comfort, and security of these devices. Integration with AI, big data, and cloud infrastructure is enabling real-time analysis and predictive insights, enhancing clinical relevance and decision-making efficiency. These innovations are making eHealth devices more scalable, reliable, and personalized across different health conditions and demographics.

From an end-use perspective, growing demand for remote patient monitoring, preventive healthcare, and personalized wellness solutions is expanding the consumer base for eHealth devices. Health systems are adopting digital tools to reduce hospital readmissions, improve chronic care management, and increase operational efficiency. In addition, consumer interest in proactive health tracking—amplified by the pandemic and rising digital literacy—is leading to higher adoption across age groups and income segments. Employers are also playing a role, integrating eHealth solutions into corporate wellness programs to boost workforce productivity and reduce healthcare costs. Furthermore, government initiatives in digital health infrastructure and telemedicine integration are providing a supportive ecosystem for growth. Reimbursement policies and regulatory clarity around digital health tools are encouraging more physicians to incorporate eHealth devices into clinical workflows. Together, these technological, structural, and behavioral drivers are accelerating the global expansion and mainstream acceptance of eHealth devices across medical and consumer health landscapes.

SCOPE OF STUDY:

The report analyzes the eHealth Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Blood Pressure Meters, Fever Meters, Glucose Meters, Care Phone / Social Alarms)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AliveCor, Inc.
• Apple Inc.
• BioTelemetry, Inc. (a Philips company)
• Boston Scientific Corporation
• Dexcom, Inc.
• Fitbit, Inc. (a Google company)
• Garmin Ltd.
• GE HealthCare
• iRhythm Technologies, Inc.
• Johnson & Johnson MedTech
• Koninklijke Philips N.V.
• Masimo Corporation
• Medtronic plc
• Omron Healthcare, Inc.
• OURA Health Ltd.
• ResMed Inc.
• Samsung Electronics Co., Ltd.
• Siemens Healthineers AG
• Withings

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.